Skip to main content

Table 3 MK ratios in different clinicopathological features

From: Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules

 

MK (ng/ml)

P value

TG (ng/ml)

P value

MK/TG (ng/mg)

P value

FT4(pmol/L)

P value

MK/FT4(μg/pmol)

P value

FT4/MK (pmol /μg)

P value

Number of nodules

 

0.392

 

0.431

 

0.158

 

0.449

 

0.324

 

0.324

 Solitary

0.47 (0.02,16.93)

 

5003.25 (155,230,050)

 

96 (2.10,4021.67)

 

3.8 (0.33,78.57)

 

0.1 (0.002,6.84)

 

9.57 (0.15,563.76)

 

 Multiple

0.39 (0.02,12.07)

 

5711.25 (560,3,224,500)

 

70.97 (1.52,1202.08)

 

4.06 (0.48,141.3)

 

0.07 (0.001,8.21)

 

14.81 (0.12,910.94)

 

aMTD

 

0.000*

 

0.691

 

0.009*

 

0.395

 

0.001*

 

0.001*

  ≤ 1 cm

0.27 (0.013,12.07)

 

5711.29 (171,230,050)

 

58.83 (1.52,4021.37)

 

4.05 (0.54,96.95)

 

0.06 (0.001,8.21)

 

17.06 (0.12,910.94)

 

 >1 cm,  ≤ 2 cm

0.56 (0.06,16.93)

 

4119.5 (155,178,100)

 

161.09 (3.56,2380.22)

 

3.85 (0.33,80.69)

 

0.32 (0.004,6.32)

 

3.16 (0.16,222.71)

 

 >2 cm, ≤4 cm

2.50 ± 2.84

 

8205 (199,3,224,500)

 

389.81 ± 516.56

 

2.29 (0.39,141.3)

 

1.07 ± 1.47

 

9.53 ± 16.76

 

bETE

 

0.241

 

0.009*

 

0.001*

 

0.009*

 

0.003*

 

0.003*

 No invasion

0.37 (0.015,16.93)

 

9230 (1845,300,500)

 

40.31 (0.31,1766.59)

 

6.56 (0.39,332.9)

 

0.05 (0.001,8.21)

 

21.92 (0.12,708.99)

 

 cCapsule and the outside

0.55 (0.02,9.79)

 

3457.25 (155,3,224,500)

 

138.95 (2.37,4021.37)

 

2.73 (0.33,141.3)

 

0.21 (0.005,6.84)

 

4.74 (0.15,222.71)

 

 dSoft tissues or strap muscles

0.35 (0.013,6.42)

 

3479.75 (1117.519935)

 

210.42 (3.99,861.67)

 

5.2 (0.51,96.96)

 

0.0096 (0.001,6.32)

 

15.66 (0.16,910.94)

 

T stage

 

0.008*

 

0.119

 

0.002*

 

0.269

 

0.002*

 

0.002*

 T1a

0.27 (0.02,12.07)

 

5807.5 (171,230,050)

 

60.50 (1.52,4021.37)

 

3.96 (0.54,89.70)

 

0.06 (0.001,8.21)

 

16.63 (0.12,708.99)

 

 T1b

0.61 (0.06,16.93)

 

5003.25 (155,178,100)

 

137.38 (3.56,2380.22)

 

4.08 (0.33,80.69)

 

0.31 (0.005,2.85)

 

3.24 (0.35,222.71)

 

 T2

1.37 (0.30,8.05)

 

8205 (199,3,224,500)

 

196.78 (2.37,1766.59)

 

2.29 (0.39,141.3)

 

0.59 (0.02,5.00)

 

1.68 (0.20,56.72)

 

 T3b

0.35 (0.11,3.22)

 

3327.25 (1117.519935)

 

210.42 (8.82,861.67)

 

3.05 (0.51,96.96)

 

0.10 (0.002,6.32)

 

15.66 (0.16,551.37)

 

 T4a

3.22 (0.01,6.42)

 

6490.5 (3255,9726)

 

332.18 (3.99,660.37)

 

9.29 (6.73,11.84)

 

0.48 (0.001,0.95)

 

455.99 (1.05,910.94)

 

N stage

 

0.006*

 

0.635

 

0.064

 

0.587

 

0.025*

 

0.025*

 N0

0.26 (0.02,9.79)

 

4645.00 (171.00,230,050.00)

 

46.35 (1.52,4021.37)

 

4.53 (0.33,78.50)

 

0.07 (0.001,6.84)

 

15.16 (0.15,708.99)

 

 N1

0.52 (0.013,16.93)

 

6162.50 (155.00,3,224,500.00)

 

111.80 (2.37,2380.22)

 

3.72 (0.39,141.30)

 

0.13 (0.001,8.21)

 

7.94 (0.12,910.94)

 
  1. a MTD maximum tumor diameter, b ETE extrathyroidal extension, c capsule and the outside invasion through the capsule and reached the outside, d soft tissues or strap muscles perithyroidal soft tissues or strap muscles
  2. *P<0.05
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us